Association of interleukin-1A, interleukin-1B and interleukin-1 receptor antagonist gene polymorphisms with multiple myeloma

References

• Jemal A, Siegel R, Ward E. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106–130
   PubMed Web of Science ®Google Scholar
• Kyle R A, Lust J A. Monoclonal gammopathies of undetermined significance. Semin Hematol 1989; 26: 176
   PubMed Web of Science ®Google Scholar
• Mazur G, Bogunia-Kubik K, Wrobel T, Karabon L, Polak M, Kuliczkowski K, et al. IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma. Immun Lett 2005; 96: 241–246
   PubMed Web of Science ®Google Scholar
• Harousseau J-L, Shaughnessy J, Jr, Richardson P. Multiple myeloma. Am Soc Hem Hematol 2004; 1: 237–256
   Google Scholar
• McCrea A P, Morris T C. Concurrent familial myeloma in Northern Ireland. Cancer 1986; 58: 394–396
   PubMed Web of Science ®Google Scholar
• Brown L M, Linet M S, Creenberg R S, Silverman D T, Hayes R B, Swanson G M, et al. Multiple myeloma and family history among blacks and whites in the US. Cancer 1999; 85: 2385–2390
   PubMed Web of Science ®Google Scholar
• Grosbois B, Jego P, Attale, Payen C, Rapp M J, Fuzibet J G, et al. Familial multiple myeloma: report of fifteen families. Br J Haematol 1999; 105: 760–770
   Web of Science ®Google Scholar
• Zheng C, Huang D, Liu L, Wu R, Bergenbrant Glas S, Osterborg A, et al. Interleukin-10 gene promoter polymorphisms in multiple myeloma. Int J Cancer 2001; 95: 184–188
   PubMed Web of Science ®Google Scholar
• Zheng C, Huang D, Bergenbrant S, Sundblad A, Osterborg A, Bjorkholm M, et al. Interleukin 6, tumour necrosis factor α, interleukin 1β and interleukin 1 receptor antagonist promoter or coding gene polymorphism in multiple myeloma. Br J Haematol 2000; 109: 39–45
   PubMed Web of Science ®Google Scholar
• Lauta V M. Interleukin-6 and the network of several cytokines in multiple myeloma: an overview of clinical and experimental data. Cytokine 2001; 16: 79–86
   PubMed Web of Science ®Google Scholar
• Lauta V M. A review of the cytokine network in multiple myeloma: diagnostic, prognostic and therapeutic implications. Cancer 2003; 97: 2440–2452
   PubMed Web of Science ®Google Scholar
• Howell W M, Rose-Jerilli M J. Interleukin-10 polymorphisms, cancer susceptibility and prognosis. Familial Cancer 2006; 5: 143–149
   PubMed Web of Science ®Google Scholar
• Howell W M, Rose-Jerilli M J. Cytokine gene polymorphisms, cancer susceptibility, and prognosis. J Nutr 2007; 137: 194–199
   PubMed Web of Science ®Google Scholar
• Nicklin M J, Barton J L, Nguyen M, FitzGerald M G, Duff G W, Kornman K. A sequenced based map of the nine genes of the human interleukin cluster. Genomics 2002; 79: 718
   PubMed Web of Science ®Google Scholar
• Arend W P, Malyak M, Guthridge C J, Gabay C. Interleukin 1 receptor antagonist: a role in biology. Ann Rev Immunol 1998; 16: 27
   PubMed Web of Science ®Google Scholar
• Dinarello C A. Biological basis for interleukin-1 in disease. Blood 1996; 87: 2095
   PubMed Web of Science ®Google Scholar
• Dinarello C A. Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann NY Acad Sci 1998; 856: 1–11
   PubMed Web of Science ®Google Scholar
• Cozzolino F, Torcia M, Aldinucci D, Rubartelli A, Miliani A, Shaw A R, et al. Production of interleukin-1 by bone marrow myeloma cells. Blood 1989; 74: 380
   PubMed Web of Science ®Google Scholar
• Yamamoto I, Kawano M, Sone T, Iwato K, Tanaka H, Ishikawa H, et al. Production of interleukin-1β, a potent bone resorbing cytokine, by cultured human myeloma cells. Cancer Res 1989; 49: 4242
   PubMed Web of Science ®Google Scholar
• Torcia M, Lucibello M, Vannier E, Fabiani S, Miliani A, Guidi G, et al. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors. Exp Hematol 1996; 24: 868–874
   PubMed Web of Science ®Google Scholar
• Lichtenstein A, Berenson J, Norman D, Zighelboim J. Production of cytokines by bone marrow cells obtained from patients with multiple myeloma. (Suppl. Blood) 1989; 74: 1266
   Google Scholar
• Carter A, Merchav S, Silvian-Draxler I, Tatarsky I. The role of interleukin-1 and tumour necrosis factor-α in human multiple myeloma. Br J Haematol 1990; 74: 424–431
   PubMed Web of Science ®Google Scholar
• Endres S, Cannon J G, Ghorbani R, Dempsey R A, Sisson S D, Lonnemann G, et al. In vitro production of IL-1 beta, IL-1 alpha, TNF and IL-2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation. Eur J Immunol 1989; 19: 2327
   PubMed Web of Science ®Google Scholar
• Hall S K, Perregaux D G, Gabel C A. Correlation of polymorphic variation in the promoter region of the interleukin-1_gene with secretion of interleukin-1_protein. Arthritis Rheum 2004; 50: 1976
   PubMed Web of Science ®Google Scholar
• Hume M, Lahdenpahja N, Santtila S. Gene polymorphisms of interleukins 1 and 10 in infectious and autoimmune diseases. Ann Med 1998; 30: 469
   PubMed Web of Science ®Google Scholar
• El Omar E M, Carrington M, Chow W H. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398–402
   PubMed Web of Science ®Google Scholar
• Demeter J, Messer G, Ramisch S, Mee J B, Giovine F S, Schmid M, et al. Polymorphisms within the second intron of the IL-1 receptor antagonist gene in patients with hematopoietic malignancies. Cytokine Mol Ther 1996; 2: 239–242
   PubMedGoogle Scholar
• Mellstedt H, Bjorkholm M, Holm G. Intermittent melphalan and prednisolone therapy in plasma cell myeloma. Acta Med Scand 1977; 202: 5–9
   PubMed Web of Science ®Google Scholar
• Pettersson D, Mellstedt H, Holm G, Bjorkholm M. Monoclonal blood lymphocytes in benign monoclonal gammopathy and multiple myeloma in relation to clinical stage. Scand J Haemat 1981; 27: 287–293
   PubMedGoogle Scholar
• Calvo J, Martinez N, Extragibel A, Calleja S, Saez-Torres C. Alellic frequence of polymorphic variation of cytokine gene (IL1A, IL1b, IL1RA, IL6, IL10, IL12p40 and INFG) in Spanish population. Immunologia 2002; 21: 76
   Google Scholar
• Kornman K S, Crane A, Wang H Y, di Giovine F S, Newman M G, Pirk F W, et al. The inteleukin 1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997; 42: 72–77
   Web of Science ®Google Scholar
• Howell W M, Turner S J, Theaker J M, Bateman A C. Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma. Eur J Immunogenetics 2003; 30: 409–414
   PubMedGoogle Scholar
• Cantagrel A, Navaux F, Loubet-Lescoulie P. Interleukin-1 beta, interleukin-1 receptor antagonist, interleukin-4 and interleukine-10 gene polymorphisms: relationship to occurrence and severity to rheumatoid arthritis. Arhritis Rheum 1999; 42: 1093–1100
   PubMed Web of Science ®Google Scholar
• Endler G, Marculescu R, Starkl P, Binder A, Geishofer G, Müller M, et al. Polymorphsims in the interleukin-1 gene cluster in children and young adults with systemic meningococcemia. Clin Chem 2006; 52: 511–514
   PubMed Web of Science ®Google Scholar
• Gowen M, Wood D D, Ihrie E J, McGuire M K, Russel R G. An interleukin 1 like factor stimulates bone resorption in vitro. Nature 1983; 306: 378–380
   PubMed Web of Science ®Google Scholar
• Bertolini D R, Nedwin G E, Bringman T S, Smith D D, Mundy G R. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumor necrosis factor. Nature 1998; 319: 516–518
   Web of Science ®Google Scholar
• Chen H, Wilkins L M, Aziz N, Cannings C, Wyllie D H, Bingle C, et al. Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genetics 2006; 15: 519–529
   PubMed Web of Science ®Google Scholar
• Chiplunkar S, Langhorne J, Kaufmann S H. Stimulation of B cell growth and differentiation by murine recombinant interleukin 1. J Immunol 1986; 137: 3748–3752
   PubMed Web of Science ®Google Scholar
• Jandl R C, Flanagan R G, Schur P H. Interleukin stimulation of human B-lumpoblast differentiation. Clin Immunol Immunopathol 1988; 46: 115–121
   PubMedGoogle Scholar
• Tatsuta T, Cheng J, Mountz J D. Intracellular IL-1beta is an inhibitor of Fas-mediated apoptosis. J Microbiol 1996; 157: 3949–3957
   Google Scholar
• Hirsch E, Irikura V M, Paul S M, Hirsch D. Functrions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci USA 1996; 93: 11008–11013
   PubMed Web of Science ®Google Scholar
• Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL 1Ra and IL-1 beta genes. Eur J Immunol 1998; 46: 115–121
   Google Scholar
• Bioque G, Crusius J B, Koutroubakis I, Bouma G, Kostense P J, Meuwissen, et al. Allelic polymorphisms in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol 1995; 102: 379–383
   PubMed Web of Science ®Google Scholar
• Lai J, Zhou D, Xia S, Shang Y, Zhu J, Pan J, et al. Association of interleukin-1 gene cluster polymorphisms with ischemic stroke in a Chinese population. Neurol Ind 2006; 54: 366–369
   PubMed Web of Science ®Google Scholar
• Jatoi A, Nguyen P L, Foster N, Sun D, Stella P J, Campbell M, et al. Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma. J Support Oncol 2007; 5: 41–46
   PubMedGoogle Scholar
• Migita K, Maeda Y, Abiru S, Nakamura M, Komori A, Miyazoe S, et al. Polymorphisms of interleukin-1beta in Japanese patients with hepatitis B virus infection. J Hepatol 2007; 46: 381–386
   PubMed Web of Science ®Google Scholar
• Lee K M, Park S K, Hamajima N, Tajima K, Choi J Y, Noh D Y, et al. Genetic polymorphisms of interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women. Breast Cancer Res Treat 2006; 96: 197–202
   PubMed Web of Science ®Google Scholar
• Carter A, Merchav S, Silvian-Draxler I, Tatarsky I. The role of interleukin and tumor necrosis factor-a in human multiple myeloma. Brit J Haematol 1990; 74: 424–431
   PubMed Web of Science ®Google Scholar
• Uboldi de Capei M, Dametto E, Fasano M E, Rendine S, Curtoni S E. Genotyping for cytokine polymorphisms: allele frequencies in the Italian population. Eur J Immunogenetics 2003; 30: 5–10
   PubMedGoogle Scholar
• Marshall S, McLaren A J, McKinney E F, Bird T, Haldar N A, Bunce M, et al. Donor cytokine genotype influences the development of acute rejection after renal transplantation. Transplantation 2001; 71: 469–476
   PubMed Web of Science ®Google Scholar
• Nieters A, Brems S, Becker N. Cross-sectional study on cytokine polymorphisms, cytokine production after T-cell stimulation and clinical parameters in a random sample of German population. Hum Genetics 2001; 108: 241–246
   PubMed Web of Science ®Google Scholar